IR LIBRARY News & Press Releases 11/14 IR FYE2018Q3 Financial Results presentation 11/11 PR Acucela Initiates Phase 3 Study of Emixustat Addressing Patients with Stargardt Disease 10/28 PR Acucela Completes PBOS Clinical Study and Validates Concept 08/21 IR FYE2018Q2 Financial Results Analyst Meeting presentation more info For information on SEC filings, please visit U.S. SEC's EDGAR service. CEO Message Corporate Governance SEC Filings Shareholders Meeting IR Presentations Financial Events Calendar FAQs Email Alerts
